Boston Scientific Corporation (FRA:BSX)
82.40
-0.40 (-0.49%)
Oct 1, 2025, 8:34 AM CET
Boston Scientific Revenue
Boston Scientific had revenue of $5.06B USD in the quarter ending June 30, 2025, with 22.84% growth. This brings the company's revenue in the last twelve months to $18.49B, up 21.44% year-over-year. In the year 2024, Boston Scientific had annual revenue of $16.75B with 17.61% growth.
Revenue (ttm)
$18.49B
Revenue Growth
+21.44%
P/S Ratio
7.83
Revenue / Employee
$348.94K
Employees
53,000
Market Cap
123.30B EUR
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 16.75B | 2.51B | 17.61% |
Dec 31, 2023 | 14.24B | 1.56B | 12.29% |
Dec 31, 2022 | 12.68B | 794.00M | 6.68% |
Dec 31, 2021 | 11.89B | 1.98B | 19.92% |
Dec 31, 2020 | 9.91B | -822.00M | -7.66% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Siemens Healthineers AG | 23.38B |
Merck KGaA | 21.22B |
Bayer Aktiengesellschaft | 46.17B |
Fresenius SE & Co. KGaA | 22.28B |
Fresenius Medical Care AG | 19.52B |
Sartorius Aktiengesellschaft | 3.47B |
Fielmann Group AG | 2.40B |
Carl Zeiss Meditec AG | 2.18B |
Boston Scientific News
- 7 days ago - Johnson & Johnson, Boston Scientific to Headline MEDevice Boston 2025 Keynote Sessions - Wallstreet:Online
- 11 days ago - Top 3 Health Care Stocks That May Explode In September - Benzinga
- 11 days ago - Top 3 Health Care Stocks That May Explode In September - Benzinga
- 14 days ago - Noteworthy Tuesday Option Activity: BSX, FDX, PYPL - Nasdaq
- 15 days ago - Relative Strength Alert For Boston Scientific - Nasdaq
- 15 days ago - Boston Scientific Breaks Below 200-Day Moving Average - Notable for BSX - Nasdaq
- 15 days ago - Peter Lynch Detailed Fundamental Analysis - BSX - Nasdaq
- 20 days ago - Pre-tax profits at Irish arm of Boston Scientific increase by 52pc to $111m - Independent Ireland